New gel shows promise for diabetic wound healing
NCT ID NCT06608303
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a gel containing a protein called GM-CSF on 40 people with diabetic wounds that were in the healing (granulation) phase. The gel aims to boost the body's own repair cells to help wounds close faster. Researchers measured how much the wound size shrank and checked for side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- human granulocyte macrophage stimulating factor gel (JinFuNing)
- What this could lead to
- If it works, this gel could speed up healing of diabetic wounds, reducing infection risk and improving quality of life.
- What could go wrong
- This is a small, completed study with only 40 participants. The results may not apply to all diabetic wounds, and the gel may not work better than standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC WOUND are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Peking University Third Hospital
Beijing, Beijing Municipality, 100191, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.